Does the FDD mention any pending litigation involving the Dermani Medspa Marks?
Dermani_Medspa Franchise · 2025 FDDAnswer from 2025 FDD Document
There are no currently effective material determinations of the USPTO, the Trademark Trial and Appeal Board, the trademark administrator of any state, or any court, and no pending infringement,
opposition, or cancellation proceeding, or any pending material litigation, involving the Marks. There is no agreement in effect which significantly limits our rights to use or license the Marks in any state in a manner material to the franchise, and we know of no superior prior rights or infringing uses that could materially affect your use of the Marks in any state.
Source: Item 13 — TRADEMARKS, SERVICE MARKS, TRADE NAMES, LOGOTYPES, AND COMMERCIAL SYMBOLS (FDD pages 46–47)
What This Means (2025 FDD)
According to Dermani Medspa's 2025 Franchise Disclosure Document, there are no pending lawsuits regarding the company's trademarks. The FDD states that there are no currently effective material determinations by the USPTO, the Trademark Trial and Appeal Board, or any court, and no pending infringement, opposition, or cancellation proceeding, or any pending material litigation, involving the Marks. This indicates that Dermani Medspa is not currently involved in any legal disputes concerning its trademarks. The parent company, LazCoz, owns and has registered the dermani MEDSPA® mark with the U.S. Patent and Trademark Office.
This absence of litigation is a positive sign for potential franchisees. Trademark disputes can be costly and disruptive, potentially impacting a franchisee's ability to use the brand's name and logos. The FDD also mentions a trademark license agreement between Dermani Medspa and LazCoz, ensuring Dermani Medspa has the right to use and license the marks. If Dermani Medspa were to lose its rights to the marks, LazCoz is required to allow franchisees to maintain their rights to use the Proprietary Marks in accordance with their franchise agreements, and the franchise agreements will be assigned to LazCoz.
Prospective franchisees should still conduct their own due diligence to verify this information. While the FDD provides a snapshot in time, the legal landscape can change. It would be prudent to ask Dermani Medspa about any past trademark disputes and to monitor the USPTO database for any new filings that could affect the brand. Additionally, franchisees have a responsibility to notify Dermani Medspa immediately of any apparent infringement or challenge to the use of any Mark.